Clinical Trial Update: 3-Dimensional Virtual Reality Modelling With Intravascular Indocyanine Green Fluorescence Mapping for Targeted Pulmonary Segmental Resection Trial [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating a 3D virtual reality planning approach combined with indocyanine green fluorescence mapping to guide targeted pulmonary se…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Indocyanine Green (Indocyanine Green)

Snippet

Sponsor: St. Joseph's Healthcare Hamilton | Conditions: Non Small Cell Lung Cancer | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING